Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Delirium × Propofol × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 3 Ovarian Neoplasms 2 Neoplasms 2 Urinary Bladder Neoplasms 1 Tuberculosis, Pulmonary 1 Thoracic Diseases 1 Sedation 1 Neoplastic Cells, Circulating 1 Liver Neoplasms 1 Intraoral Tumor 1 Hypoxia 1 Esophageal Neoplasms 1 Emergence Delirium 1 Disease Progression 1 Delirium 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

remimazolam 1 Propofol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04532606 2025-07-30

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Peking University First Hospital

Phase 4 Recruiting

Emergence Delirium, Urinary Bladder Neoplasms, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon ⚡